|
|
Volumn 3, Issue , 1998, Pages 225-246
|
|
Treatment options for benign prostatic hyperplasia
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
1,4 DIHYDRO 2,6 DIMETHYL 4 (4 NITROPHENYL) 3,5 PYRIDINEDICARBOXYLIC ACID 3 AMIDE 5 [3 (4,4 DIPHENYL 1 PIPERIDINYL)PROPYL]AMIDE;
3 [2 (2,3,3A,4,5,9B HEXAHYDRO 6 METHOXY 1H BENZ[E]ISOINDOL 2 YL)ETHYL]PYRIDO[3',4':4,5]THIENO[3,2 D]PYRIMIDINE 2,4(1H,3H) DIONE;
3 [3 [4 [4 FLUORO 2 (2,2,2 TRIFLUOROETHOXY)PHENYL] 1 PIPERAZINYL]PROPYL] 5 METHYL 1H PYRIMIDINE 2,4 DIONE;
8 [3 [4 (2 METHOXYPHENYL) 1 PIPERAZINYL]PROPYLCARBAMOYL] 3 METHYLFLAVONE;
ALPHA ADRENERGIC RECEPTOR BLOCKING AGENT;
ANDROGEN RECEPTOR;
ANDROSTANOLONE;
ANTIANDROGEN;
AROMATASE INHIBITOR;
ATAMESTANE;
BICALUTAMIDE;
CEP 075;
CEPHALON;
DOXAZOSIN;
ESTROGEN RECEPTOR;
FINASTERIDE;
FLUTAMIDE;
GG 818;
GONADORELIN AGONIST;
GONADORELIN ANTAGONIST;
GROWTH FACTOR;
INDORAMIN;
NAFTOPIDIL;
PROTEIN TYROSINE KINASE INHIBITOR;
REC 22009;
SILODOSIN;
SL 890591;
SL 91 0893;
STEROID 5ALPHA REDUCTASE INHIBITOR;
TERAZOSIN;
UNCLASSIFIED DRUG;
UNINDEXED DRUG;
HUMAN;
MALE;
MALE SEXUAL DYSFUNCTION;
MICTURITION;
NOCTURIA;
PHYTOTHERAPY;
PROSTATE HYPERTROPHY;
REVIEW;
URINE FLOW RATE;
|
|
EID: 0031968778
PISSN: 13619195
EISSN: None
Source Type: Journal
DOI: 10.1517/14728214.3.1.225 Document Type: Review |
|
Times cited : (8)
|
|
References (62)
|
